Related Experiment Video

Updated: Aug 17, 2026

Highly Sensitive Measurement of Glomerular Permeability in Mice with Fluorescein Isothiocyanate-polysucrose 70
09:16

Highly Sensitive Measurement of Glomerular Permeability in Mice with Fluorescein Isothiocyanate-polysucrose 70

Published on: August 9, 2019

Microalbuminuria and cardiovascular risk

Janaka Karalliedde1, Giancarlo Viberti

  • 1Department of Diabetes, Endocrinology and Internal Medicine, Guy's, King's and St Thomas' (GKT) School of Medicine, King's College London, London, United Kingdom.

American Journal of Hypertension
|October 16, 2004
PubMed

Insights

Microalbuminuria, an early sign of vascular dysfunction, significantly increases cardiovascular risks, especially in type 2 diabetes. Renin-angiotensin system blockade effectively treats microalbuminuria, preventing kidney disease progression.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Microalbuminuria indicates widespread vascular dysfunction, affecting 6-10% of general populations in the US and Europe.
  • Elevated albumin excretion rates, even within normal limits, are linked to increased cardiovascular morbidity and mortality.
  • Microalbuminuria independently predicts renal disease, stroke, myocardial infarction, and left ventricular dysfunction.

Purpose of the Study:

  • To highlight microalbuminuria as a critical marker for cardiovascular risk.
  • To emphasize the prognostic value of screening for microalbuminuria.
  • To review therapeutic strategies for managing microalbuminuria and its associated risks.

Main Methods:

  • Analysis of prevalence data from population surveys.
  • Review of clinical studies demonstrating the independent risk associated with microalbuminuria.
  • Evaluation of evidence supporting antihypertensive therapies, particularly renin-angiotensin system blockade.

Main Results:

  • Microalbuminuria doubles cardiovascular event risk in type 2 diabetes patients, independent of traditional risk factors.
  • Urinary albumin excretion predicts target organ damage, including renal disease and cardiovascular events.
  • Antihypertensive therapy, especially renin-angiotensin system inhibitors, effectively controls and can reverse microalbuminuria.

Conclusions:

  • Screening for microalbuminuria provides crucial prognostic information for cardiovascular risk assessment.
  • Blockade of the renin-angiotensin system is the preferred treatment for microalbuminuria, halting or reversing progression.
  • Therapeutic interventions can prevent the progression of renal disease and improve cardiovascular outcomes.

More Related Videos

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...